About

About EpiCypher, Inc. About EpiCypher EpiCypher is developing products and services to advance the science of epigenetic regulation and improve human health. In recent years, we have delivered major innovations for biochemical and genomic applications to study chromatin dynamics, including CUTANA™ genomic mapping assays for CUT&RUN and CUT&Tag. With decades of experience and active collaborations in epigenetics research (see co-authored publications), EpiCypher uniquely understands the challenges facing this field – and how to solve them. Our scientists are leading the development of innovative products and high-throughput services that are backed by a rigorous scientific approach, validated protocols, and quantitative assay controls. EpiCypher works with groups spanning academia, industry, and clinical trials. These experiences inspire us to push technological boundaries, making chromatin more accessible to answer nature’s most complex and enduring questions. As your research partner, our team can help take your science to the next level.